Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study

Thesis (MMed) -- Stellenbosch University, 2021.

Saved in:
Bibliographic Details
Main Author: Essajee, Farida
Other Authors: Van Toorn, Ronald
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2021
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613986216738816
access_status_str Open Access
author Essajee, Farida
author2 Van Toorn, Ronald
author_browse Essajee, Farida
Van Toorn, Ronald
author_facet Van Toorn, Ronald
Essajee, Farida
author_sort Essajee, Farida
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MMed) -- Stellenbosch University, 2021.
format Thesis
id oai:scholar.sun.ac.za:10019.1/124264
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:44:51.414Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/124264 Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study Essajee, Farida Van Toorn, Ronald Moosa, Shahida Solomons, Regan Human chromosome abnormalities -- Diagnosis High-throughput nucleotide sequencing Neonatal encephalopathy Genetic disorders -- Diagnosis -- Sub-Saharan Africa Epilepsy – Hospitals -- Sub-Saharan Africa Epileptic children -- Sub-Saharan Africa Thesis (MMed) -- Stellenbosch University, 2021. ENGLISH ABSTRACT: Introduction: The developmental and epileptic encephalopathies (DEE) are a heterogeneous group of rare neurodevelopmental disorders, characterised by early-onset seizures that are often intractable, electroencephalographic abnormalities, and developmental delay or regression. Studies have shown that 70% of epilepsy cases have a genetic basis. Next-generation sequencing (NGS) technologies have led to the identification of several epilepsy-related genes, including those responsible for DEE. The reported diagnostic yield of an NGS-based testing for patients with epilepsy ranges from 10 to 40%, depending on the test and the phenotypes among the studied cohorts. Objectives: The aim of this study was to evaluate the diagnostic yield of NGS-based epilepsy gene panel in children with DEE and to assess the value of the genetic results to the parents and managing physicians. Design: A prospective cohort study of 41 consecutive children diagnosed with DEE (onset before 3 years of age) was recruited over a 2-year period (2019-2021). Pre- and post-test genetic counselling were offered to all study participants. The results were classified into three categories: positive (pathogenic/likely pathogenic), inconclusive (variant of unknown significance), or negative. After the results were obtained, questionnaires were administered to both the physicians and the parents. Result interpretation and careful matching of the variant to the clinical phenotype was carried out with the help of a medical geneticist. Results: We found a positive genetic diagnosis in 20 of 41 (48%) children. Variants in SCN1A (n=5), KANSL1 (n=2), KCNQ2 (n=2) and CDKL5 (n=2) accounted for the greatest number of positive findings. Rarer genetic findings included IQSEC2, KCNMA1, SMC1A and STXBP. All except 1 of the pathogenic variants identified fully explained and matched the respective phenotypic description in the patient at time of diagnosis. Gene-specific treatment changes were initiated in 26% patients following the genetic diagnosis. Both parents and physicians expressed usefulness of genetic testing in patients with DEE. Conclusion: With this study, we show that an NGS gene panel is highly effective in diagnosing South African children with DDE. The study diagnostic yield (48%) is similar to previously reported paediatric cohorts, and the genetic findings proved useful for therapeutic decision making and genetic counseling. Although the diagnostic yield in this study was high, therapeutic consequences and ultimate improvement of the patient's clinical state were still limited. "Geen opsomming beskikbaar." Masters 2021-11-25T09:08:25Z 2022-02-22T10:21:37Z 2021-11-25T09:08:25Z 2021-12 Thesis http://hdl.handle.net/10019.1/124264 en_ZA Stellenbosch University 52 pages application/pdf Stellenbosch : Stellenbosch University
spellingShingle Human chromosome abnormalities -- Diagnosis
High-throughput nucleotide sequencing
Neonatal encephalopathy
Genetic disorders -- Diagnosis -- Sub-Saharan Africa
Epilepsy – Hospitals -- Sub-Saharan Africa
Epileptic children -- Sub-Saharan Africa
Essajee, Farida
Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study
title Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study
title_full Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study
title_fullStr Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study
title_full_unstemmed Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study
title_short Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study
title_sort utility of genetic testing in children with developmental and epileptic encephalopathy dee at a tertiary hospital in south africa a prospective study
topic Human chromosome abnormalities -- Diagnosis
High-throughput nucleotide sequencing
Neonatal encephalopathy
Genetic disorders -- Diagnosis -- Sub-Saharan Africa
Epilepsy – Hospitals -- Sub-Saharan Africa
Epileptic children -- Sub-Saharan Africa
url http://hdl.handle.net/10019.1/124264
work_keys_str_mv AT essajeefarida utilityofgenetictestinginchildrenwithdevelopmentalandepilepticencephalopathydeeatatertiaryhospitalinsouthafricaaprospectivestudy